Exact Mass: 331.147

Exact Mass Matches: 331.147

Found 276 metabolites which its exact mass value is equals to given mass value 331.147, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Sekisanin

8H-[1,3]Dioxolo[6,7][2]benzopyrano[3,4-c]indol-6a(3H)-ol,4,4a,5,6-tetrahydro-3-methoxy-5-methyl-, (3S,4aS,6aS,13bS)-

C18H21NO5 (331.142)

Ambelline

Crinan-18-ol, 1,2-didehydro-3,9-dimethoxy-, (3alpha,18S)-

C18H21NO5 (331.142)

Pretazettine

(1S,11R,13R,16S,18S)-18-methoxy-15-methyl-5,7,12-trioxa-15-azapentacyclo[11.7.0.0¹,¹⁶.0²,¹⁰.0⁴,⁸]icosa-2,4(8),9,19-tetraen-11-ol

C18H21NO5 (331.142)

Pretazettine, also known as pretazettine hydrochloride, (6abeta,8beta)-isomer, is a member of the class of compounds known as tazettine-type amaryllidaceae alkaloids. Tazettine-type amaryllidaceae alkaloids are amaryllidaceae alkaloids derived from the haemanthamine-type alkaloids, which are characterized as a linkage between C6 and C11 by an oxygen atom to form a [3,4-g]benzopyran framework. Pretazettine is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). Pretazettine can be found in lovage, which makes pretazettine a potential biomarker for the consumption of this food product.

2-O-Acetylpseudolycorine

C18H21NO5 (331.142)

Pitolisant hydrochloride

C17H27Cl2NO (331.147)

C78272 - Agent Affecting Nervous System Pitolisant hydrochloride is a potent and selective nonimidazole inverse agonist at the recombinant human histamine H3 receptor (Ki=0.16 nM).

Alitame

3-Amino-3-({1-[(2,2,4,4-tetramethylthietan-3-yl)-C-hydroxycarbonimidoyl]ethyl}-C-hydroxycarbonimidoyl)propanoate

C14H25N3O4S (331.1566)

Alitame is a sweetening agent. It is intensely sweet, approximately 2000 times sweeter than sucrose. Its use is currently (1999) permitted in Australia, New Zealand, Indonesia and China. Alitame is an artificial sweetener developed by Pfizer in the early 1980s and currently marketed in some countries under the brand name Aclame. Like aspartame, alitame is an aspartic acid-containing dipeptide. Most dipeptides are not sweet, but the unexpected discovery of aspartame in 1965 led to a search for similar compounds that shared its sweetness. Alitame is one such second-generation dipeptide sweetener. Neotame, developed by the owners of the NutraSweet brand, is another. Sweetening agent. Intensely sweet, approx. 2000 x sucrose. Use currently (1999) permitted in Australia, New Zealand, Indonesia and China

16alpha, 17-epoxy gibberellin A9

(2R,2R,5R,8R,9S,10R,11S)-11-methyl-16-oxo-15-oxaspiro[oxirane-2,6-pentacyclo[9.3.2.1⁵,⁸.0¹,¹⁰.0²,⁸]heptadecane]-9-carboxylate

C19H23O5- (331.1545)

16alpha, 17-epoxy gibberellin a9 is also known as 16α, 17-epoxy ga9. 16alpha, 17-epoxy gibberellin a9 is practically insoluble (in water) and a weakly acidic compound (based on its pKa). 16alpha, 17-epoxy gibberellin a9 can be found in a number of food items such as mugwort, natal plum, radish, and prickly pear, which makes 16alpha, 17-epoxy gibberellin a9 a potential biomarker for the consumption of these food products. 16α, 17-epoxy gibberellin a9 is also known as 16α, 17-epoxy ga9. 16α, 17-epoxy gibberellin a9 is practically insoluble (in water) and a weakly acidic compound (based on its pKa). 16α, 17-epoxy gibberellin a9 can be found in a number of food items such as mugwort, natal plum, radish, and prickly pear, which makes 16α, 17-epoxy gibberellin a9 a potential biomarker for the consumption of these food products.

Stephabyssine

C18H21NO5 (331.142)

Stemonamide

C18H21NO5 (331.142)

(+)-O9-Demethyl-5a-methoxyhomolycorine

(+)-5-Methoxy-9-O-demethylhomolycorine

C18H21NO5 (331.142)

11-hydroxycephalotaxine

11alpha-Hydroxycephalotaxine

C18H21NO5 (331.142)

6-methoxy-7-(2-methoxy-3-methyl-but-3-enyl)-9-methyl-9H-[1,3]dioxolo[4,5-h]quinolin-8-one|Me ether -Ptelefolidine|O-methyl-ptelefolidine|Ptelefolidinmethylether

C18H21NO5 (331.142)

6-Hydroxy-buphanidrine

C18H21NO5 (331.142)

2alpha-hydroxy-6-O-methyloduline

C18H21NO5 (331.142)

4,8-dimethoxy-5-methyl-7-(3-methyl-but-2-enyl)-5H-[1,3]dioxolo[4,5-g]quinolin-6-one|Ptelecortin|Ptelecortine

C18H21NO5 (331.142)

7alpha-hydroxy-erythratine|cristanine B

C18H21NO5 (331.142)

Crinamine,6-methoxy-

C18H21NO5 (331.142)

1-(4,8-dimethoxy-furo[2,3-b]quinolin-7-yloxy)-3-methyl-butan-2-ol|dihydro-evodine|dihydro-evoxoidine|Dihydroevoxoidin|evodine

C18H21NO5 (331.142)

littoraline

C18H21NO5 (331.142)

Gln Gln Gly

C12H21N5O6 (331.1492)

Ala Gln Asn

C12H21N5O6 (331.1492)

Cys Pro Ile

C14H25N3O4S (331.1566)

Gln Asn Ala

C12H21N5O6 (331.1492)

Pro Thr Asp

C13H21N3O7 (331.1379)

Thr Pro Asp

C13H21N3O7 (331.1379)

Gly Gln Gln

C12H21N5O6 (331.1492)

Asn Gln Ala

C12H21N5O6 (331.1492)

Glu Pro Ser

C13H21N3O7 (331.1379)

Asn Ala Gln

C12H21N5O6 (331.1492)

Pro Asp Thr

C13H21N3O7 (331.1379)

Pro Ser Glu

C13H21N3O7 (331.1379)

Asp Pro Thr

C13H21N3O7 (331.1379)

Pro Glu Ser

C13H21N3O7 (331.1379)

Ser Pro Glu

C13H21N3O7 (331.1379)

Alitame

3-amino-3-({1-[(2,2,4,4-tetramethylthietan-3-yl)carbamoyl]ethyl}carbamoyl)propanoic acid

C14H25N3O4S (331.1566)

CONFIDENCE standard compound; INTERNAL_ID 5808

C18H21NO5_Tazettine

8H-[1,3]Dioxolo[6,7][2]benzopyrano[3,4-c]indol-6a(3H)-ol,4,4a,5,6-tetrahydro-3-methoxy-5-methyl-, (3S,4aS,6aS,13bS)-

C18H21NO5 (331.142)

Tazettine

(1S,13S,16R,18S)-18-methoxy-15-methyl-5,7,12-trioxa-15-azapentacyclo[11.7.0.01,16.02,10.04,8]icosa-2,4(8),9,19-tetraen-13-ol

C18H21NO5 (331.142)

Origin: Plant; SubCategory_DNP: Isoquinoline alkaloids, Amaryllidaceae alkaloids

Ala Ala Gly Asn

(2S)-2-{2-[(2S)-2-[(2S)-2-aminopropanamido]propanamido]acetamido}-3-carbamoylpropanoic acid

C12H21N5O6 (331.1492)

Ala Ala Asn Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]propanamido]-3-carbamoylpropanamido]acetic acid

C12H21N5O6 (331.1492)

Ala Gly Ala Asn

(2S)-2-[(2S)-2-{2-[(2S)-2-aminopropanamido]acetamido}propanamido]-3-carbamoylpropanoic acid

C12H21N5O6 (331.1492)

Ala Gly Gly Gln

(2S)-2-(2-{2-[(2S)-2-aminopropanamido]acetamido}acetamido)-4-carbamoylbutanoic acid

C12H21N5O6 (331.1492)

Ala Gly Asn Ala

(2S)-2-[(2S)-2-{2-[(2S)-2-aminopropanamido]acetamido}-3-carbamoylpropanamido]propanoic acid

C12H21N5O6 (331.1492)

Ala Gly Gln Gly

2-[(2S)-2-{2-[(2S)-2-aminopropanamido]acetamido}-4-carbamoylbutanamido]acetic acid

C12H21N5O6 (331.1492)

Ala Asn Ala Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanamido]propanamido]acetic acid

C12H21N5O6 (331.1492)

Ala Asn Gly Ala

(2S)-2-{2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanamido]acetamido}propanoic acid

C12H21N5O6 (331.1492)

Ala Gln Gly Gly

2-{2-[(2S)-2-[(2S)-2-aminopropanamido]-4-carbamoylbutanamido]acetamido}acetic acid

C12H21N5O6 (331.1492)

Gly Ala Ala Asn

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)propanamido]propanamido]-3-carbamoylpropanoic acid

C12H21N5O6 (331.1492)

Gly Ala Gly Gln

(2S)-2-{2-[(2S)-2-(2-aminoacetamido)propanamido]acetamido}-4-carbamoylbutanoic acid

C12H21N5O6 (331.1492)

Gly Ala Asn Ala

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)propanamido]-3-carbamoylpropanamido]propanoic acid

C12H21N5O6 (331.1492)

Gly Ala Gln Gly

2-[(2S)-2-[(2S)-2-(2-aminoacetamido)propanamido]-4-carbamoylbutanamido]acetic acid

C12H21N5O6 (331.1492)

Gly Gly Ala Gln

(2S)-2-[(2S)-2-[2-(2-aminoacetamido)acetamido]propanamido]-4-carbamoylbutanoic acid

C12H21N5O6 (331.1492)

Gly Gly Gln Ala

(2S)-2-[(2S)-2-[2-(2-aminoacetamido)acetamido]-4-carbamoylbutanamido]propanoic acid

C12H21N5O6 (331.1492)

Gly Asn Ala Ala

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]propanamido]propanoic acid

C12H21N5O6 (331.1492)

Gly Gln Ala Gly

2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-4-carbamoylbutanamido]propanamido]acetic acid

C12H21N5O6 (331.1492)

Gly Gln Gly Ala

(2S)-2-{2-[(2S)-2-(2-aminoacetamido)-4-carbamoylbutanamido]acetamido}propanoic acid

C12H21N5O6 (331.1492)

Cys Pro Ile

C14H25N3O4S1 (331.1566)

Pro Leu Cys

C14H25N3O4S1 (331.1566)

Ile Cys Pro

C14H25N3O4S1 (331.1566)

Leu Pro Cys

C14H25N3O4S1 (331.1566)

Pro Cys Leu

C14H25N3O4S1 (331.1566)

Thr Asp Pro

C13H21N3O7 (331.1379)

Cys Ile Pro

C14H25N3O4S1 (331.1566)

Asn Ala Ala Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]propanamido]propanamido]acetic acid

C12H21N5O6 (331.1492)

Asn Ala Gly Ala

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]propanamido]acetamido}propanoic acid

C12H21N5O6 (331.1492)

Ile Pro Cys

C14H25N3O4S1 (331.1566)

Gln Gly Gln

C12H21N5O6 (331.1492)

Asn Gly Ala Ala

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}propanamido]propanoic acid

C12H21N5O6 (331.1492)

Glu Ser Pro

C13H21N3O7 (331.1379)

Asp Thr Pro

C13H21N3O7 (331.1379)

Gln Ala Asn

C12H21N5O6 (331.1492)

Gln Ala Gly Gly

2-{2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]propanamido]acetamido}acetic acid

C12H21N5O6 (331.1492)

Cys Pro Leu

C14H25N3O4S1 (331.1566)

Gln Gly Ala Gly

2-[(2S)-2-{2-[(2S)-2-amino-4-carbamoylbutanamido]acetamido}propanamido]acetic acid

C12H21N5O6 (331.1492)

Gln Gly Gly Ala

(2S)-2-(2-{2-[(2S)-2-amino-4-carbamoylbutanamido]acetamido}acetamido)propanoic acid

C12H21N5O6 (331.1492)

Leu Cys Pro

C14H25N3O4S1 (331.1566)

Cys Leu Pro

C14H25N3O4S1 (331.1566)

Pro Ile Cys

C14H25N3O4S1 (331.1566)

Pro Cys Ile

C14H25N3O4S1 (331.1566)

Ser Glu Pro

C13H21N3O7 (331.1379)

Ala Asn Gln

C12H21N5O6 (331.1492)

N-benzyl-1-[(4-fluorophenyl)methyl]benzimidazol-2-amine

C21H18FN3 (331.1485)

3-[3-acetyl-4-hydroxy-5-oxo-2-(4-propan-2-ylphenyl)-2H-pyrrol-1-yl]propanoic acid

C18H21NO5 (331.142)

Flazalone

Methanone,(4-fluorophenyl)[4-(4-fluorophenyl)-4-hydroxy-1-methyl-3-piperidinyl]-

C19H19F2NO2 (331.1384)

C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic

Esmolol hydrochloride

C16H26ClNO4 (331.155)

C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists Esmolol hydrochloride is a beta adrenergic receptor blocker.

Dibenzepin hydrochloride

11H-Dibenzo[b,e][1,4]diazepin-11-one,10-[2-(dimethylamino)ethyl]-5,10-dihydro-5-methyl-, hydrochloride (1:1)

C18H22ClN3O (331.1451)

C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent > C94727 - Tricyclic Antidepressant D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents

N-Benzoyl-L-argininamide hydrochloride monohydrate

C13H22ClN5O3 (331.1411)

sedaxane

C18H19F2N3O (331.1496)

6-(3-ACETYL-4-HYDROXY-5-OXO-2-PHENYL-2,5-DIHYDRO-1H-PYRROL-1-YL)HEXANOIC ACID

C18H21NO5 (331.142)

Protokylol

4-[2-[1-(1,3-benzodioxol-5-yl)propan-2-ylamino]-1-hydroxyethyl]benzene-1,2-diol

C18H21NO5 (331.142)

C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist

TERT-BUTYL(R)-(+)-4-FORMYL-2,2-DIMETHYL-3-OXAZOLIDINECARBOXYLATE

C16H20F3NO3 (331.1395)

PROPIONYLCHOLINE P-TOLUENESULFONATE

C15H25NO5S (331.1453)

(1.ALPHA.,3A.ALPHA.,6A.ALPHA.)-HEXAHYDRO-4-OXO-CYCLOPENTA[C]PYRROLE-1,2(1H)-DICARBOXYLIC ACID-1-ETHYL2-(PHENYLMETHYL) ESTER

C18H21NO5 (331.142)

dimethyl 4-(4-methoxyphenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate

C18H21NO5 (331.142)

BRL 44408

C17H21N3O4 (331.1532)

l-homocysteinesulfinic acid

C18H21NO5 (331.142)

(+/-)-TRANS-2-BUTYLCYCLOHEXANOL

C16H25NO2S.HCl (331.1373)

Anastrozole IMpurity (alfa1 , alfa1, alfa3, alfa3-TetraMethyl-5-(1H-1,2,4-triazol-1-ylMethyl)-1,3-Benzenediacetic acid)

C17H21N3O4 (331.1532)

2-Isopropoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-6-(trifluoromethyl)pyridine

C15H21BF3NO3 (331.1567)

(R)-8-(Diphenylphosphino)-1,2,3,4-tetrahydronaphthalen-1-amine

C22H22NP (331.149)

Trimetamide

C17H21N3O4 (331.1532)

trans-(1S,2R)-sedaxane

C18H19F2N3O (331.1496)

cis-(1S,2S)-sedaxane

C18H19F2N3O (331.1496)

Phenaz

C17H21N3O4 (331.1532)

Glycyl-L-glutaminyl-L-glutamine

C12H21N5O6 (331.1492)

2-Hydroxy-5-[4-(2-hydroxy-ethyl)-piperidin-1-YL]-5-phenyl-1H-pyrimidine-4,6-dione

C17H21N3O4 (331.1532)

N-1H-imidazol-2-yl-N-[4-(1H-imidazol-2-ylamino)phenyl]benzene-1,4-diamine

C18H17N7 (331.1545)

(5-Phenyl-7-(pyridin-3-ylmethylamino)pyrazolo[1,5-a]pyrimidin-3-yl)methanol

C19H17N5O (331.1433)

6-([5-Quinolylamino]methyl)-2,4-diamino-5-methylpyrido[2,3-D]pyrimidine

C18H17N7 (331.1545)

Gibberellin A40

C19H23O5- (331.1545)

carlactone carboxylate

C19H23O5- (331.1545)

(1R,2R,5S,8S,9S,10R,11S)-5-hydroxy-11-methyl-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadecane-9-carboxylate

C19H23O5- (331.1545)

(1R,2R,5R,8R,9S,10R,11S,13R)-13-hydroxy-11-methyl-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadecane-9-carboxylate

C19H23O5- (331.1545)

(1R,2R,5R,8R,9S,10R,11R,12S)-12-hydroxy-11-methyl-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadecane-9-carboxylate

C19H23O5- (331.1545)

16alpha, 17-epoxy GA9

C19H23O5- (331.1545)

Sekisanolin

8H-[1,3]Dioxolo[6,7][2]benzopyrano[3,4-c]indol-6a(3H)-ol,4,4a,5,6-tetrahydro-3-methoxy-5-methyl-, (3S,4aS,6aS,13bS)-

C18H21NO5 (331.142)

N-(1-ethyl-6-methyl-3-pyrazolo[3,4-b]quinolinyl)-4-pyridinecarboxamide

C19H17N5O (331.1433)

gibberellin A4(1-)

C19H23O5- (331.1545)

A gibberellin carboxylic acid anion that is the conjugate base of gibberellin A4, obtained by deprotonation of the carboxy group.

gibberellin A20(1-)

C19H23O5- (331.1545)

Conjugate base of gibberellin A20.

(15R)-9,15-Dimethoxy-5,7-dioxa-12-azapentacyclo[10.5.2.01,13.02,10.04,8]nonadeca-2,4(8),9,16-tetraen-18-ol

C18H21NO5 (331.142)

2-[(6-ethyl-4-methylquinazolin-2-yl)amino]quinazolin-4(1H)-one

C19H17N5O (331.1433)

1-[(E)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]-3,4-dihydro-2H-azepin-7-one

C18H21NO5 (331.142)

trans-(1R,2S)-sedaxane

C18H19F2N3O (331.1496)

Cys-Pro-Leu

C14H25N3O4S (331.1566)

Ala-Gln-Asn

C12H21N5O6 (331.1492)

1-Tert-butyl-5-[(4-ethoxyanilino)methylidene]-1,3-diazinane-2,4,6-trione

C17H21N3O4 (331.1532)

1,7,7-trimethyl-N-(4-nitrophenyl)-2-oxo-4-bicyclo[2.2.1]heptanecarbohydrazide

C17H21N3O4 (331.1532)

1-Epijosephinine

C18H21NO5 (331.142)

cis-(1R,2R)-sedaxane

C18H19F2N3O (331.1496)

Ser-Pro-Glu

C13H21N3O7 (331.1379)

Asp-Thr-Pro

C13H21N3O7 (331.1379)

Gln-Gln-Gly

C12H21N5O6 (331.1492)

Glu-Ser-Pro

C13H21N3O7 (331.1379)

Pro-Asp-Thr

C13H21N3O7 (331.1379)

Ser-Glu-Pro

C13H21N3O7 (331.1379)

Asp-Pro-Thr

C13H21N3O7 (331.1379)

Glu-Pro-Ser

C13H21N3O7 (331.1379)

Ile-Pro-Cys

C14H25N3O4S (331.1566)

Pro-Glu-Ser

C13H21N3O7 (331.1379)

Methyl 3-{4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl}propanoate hydrochloride

C16H26ClNO4 (331.155)

Ala-Asn-Gln

C12H21N5O6 (331.1492)

Cys-Ile-Pro

C14H25N3O4S (331.1566)

Pro-Cys-Ile

C14H25N3O4S (331.1566)

Pro-Thr-Asp

C13H21N3O7 (331.1379)

Thr-Asp-Pro

C13H21N3O7 (331.1379)

Cys-Pro-Ile

C14H25N3O4S (331.1566)

Gln-Ala-Asn

C12H21N5O6 (331.1492)

Thr-Pro-Asp

C13H21N3O7 (331.1379)

Asn-Ala-Gln

C12H21N5O6 (331.1492)

Asn-Gln-Ala

C12H21N5O6 (331.1492)

Cys-Leu-Pro

C14H25N3O4S (331.1566)

Gln-Asn-Ala

C12H21N5O6 (331.1492)

Gln-Gly-Gln

C12H21N5O6 (331.1492)

Ile-Cys-Pro

C14H25N3O4S (331.1566)

Leu-Cys-Pro

C14H25N3O4S (331.1566)

Leu-Pro-Cys

C14H25N3O4S (331.1566)

Pro-Cys-Leu

C14H25N3O4S (331.1566)

Pro-Ile-Cys

C14H25N3O4S (331.1566)

Pro-Leu-Cys

C14H25N3O4S (331.1566)

Pro-Ser-Glu

C13H21N3O7 (331.1379)

(11R)-carlactonoate

C19H23O5- (331.1545)

2,5-Dihydroxy-4-(2-hydroxyphenyl)-5-(methylamino)-3-phenylpentanoic acid

C18H21NO5 (331.142)

N(2)-[4-(indol-3-yl)butanoyl]-L-glutamine

C17H21N3O4 (331.1532)

Pretazettine

C18H21NO5 (331.142)

LSM-1309

C18H21NO5 (331.142)

Gly-Gln-Gln

C12H21N5O6 (331.1492)

BRL-44408 (maleate)

C17H21N3O4 (331.1532)

BRL-44408 maleate is an α2A-adrenoceptor antagonist (Ki: 8.5 nM). BRL-44408 maleate has antidepressant and analgesic activity. BRL-44408 also improves cecal ligation puncture (CLP)-induced acute lung injury[1][2].

(1s,13s,16r,18s)-18-methoxy-15-methyl-5,7,12-trioxa-15-azapentacyclo[11.7.0.0¹,¹⁶.0²,¹⁰.0⁴,⁸]icosa-2,4(8),9,19-tetraen-13-ol

C18H21NO5 (331.142)

2,6-dimethyl-8-(1,4,6-trihydroxy-3h-isoindol-5-yl)octa-2,6-dienoic acid

C18H21NO5 (331.142)

(2z,4z)-n-[2-(acetyloxy)-2-methylpropyl]-5-(2h-1,3-benzodioxol-5-yl)penta-2,4-dienimidic acid

C18H21NO5 (331.142)

(1s,13s,15r,19r)-19-hydroxy-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9-trien-15-yl acetate

C18H21NO5 (331.142)

9,15-dimethoxy-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraen-18-ol

C18H21NO5 (331.142)

(11s,12s,15s)-13-methoxy-5,7,21-trioxa-19-azahexacyclo[11.7.1.0²,¹⁰.0⁴,⁸.0¹¹,¹⁵.0¹⁵,¹⁹]henicosa-2,4(8),9-trien-12-ol

C18H21NO5 (331.142)

5-hydroxy-4,11-dimethoxy-16-methyl-9-oxa-16-azatetracyclo[8.7.0.0²,⁷.0¹³,¹⁷]heptadeca-2(7),3,5,12-tetraen-8-one

C18H21NO5 (331.142)

tazettin

C18H21NO5 (331.142)

(1s,11s,13s,15s,18s)-11,15-dimethoxy-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraen-18-ol

C18H21NO5 (331.142)

(1r,13r,15r,18s)-9,15-dimethoxy-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraen-18-ol

C18H21NO5 (331.142)

11-hydroxycephalotaxine

C18H21NO5 (331.142)

{"Ingredient_id": "HBIN000440","Ingredient_name": "11-hydroxycephalotaxine","Alias": "NA","Ingredient_formula": "C18H21NO5","Ingredient_Smile": "COC1=CC23CCCN2CC(C4=CC5=C(C=C4C3C1O)OCO5)O","Ingredient_weight": "331.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "9900","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "285343","DrugBank_id": "NA"}